Skip to main content
. 2020 Apr 17;12(4):986. doi: 10.3390/cancers12040986

Figure 3.

Figure 3

Kaplan–Meier estimates (progression-free survival, PFS) of patients with (n = 6) and without JAK3 mutation (n = 39). The Log-rank (Mantel–Cox) test was applied. No differences in overall survival were observed.